Payments to Acquire Property, Plant, and Equipment in USD of IGC Pharma, Inc. from 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
IGC Pharma, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment history and change rate from 2010 to Q2 2025.
  • IGC Pharma, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 30 Jun 2025 was $8,000, a 79% decline year-over-year.
  • IGC Pharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $112,000, a 19% decline from 2023.
  • IGC Pharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $138,000, a 55% decline from 2022.
  • IGC Pharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $310,000, a 31% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

IGC Pharma, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $8,000 -$30,000 -79% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q2 2024 $38,000 +$18,000 +90% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q2 2023 $20,000 -$107,000 -84% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2025 Q1
Q2 2022 $127,000 +$34,000 +37% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2024 Q1
Q2 2021 $93,000 -$851,000 -90% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2023 Q1
Q2 2020 $944,000 -$229,000 -20% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2022 Q1
Q2 2019 $1,173,000 +$1,170,000 +39000% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020 2021 Q1
Q2 2018 $3,000 -$851 -22% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2020 Q1
Q2 2017 $3,851 +$745 +24% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2019 Q1
Q2 2016 $3,106 +$2,544 +453% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2017 2018 Q1
Q2 2015 $562 -$290,933 -100% 01 Apr 2015 30 Jun 2015 10-Q 16 Aug 2016 2017 Q1
Q2 2014 $291,495 +$291,495 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2016 Q1
Q2 2013 $0 $0 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2015 Q1
Q2 2012 $0 $0 01 Apr 2012 30 Jun 2012 10-Q/A 21 Aug 2012 2012 Q1
Q2 2011 $0 01 Apr 2011 30 Jun 2011 10-Q/A 21 Aug 2012 2012 Q1

IGC Pharma, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $112,000 -$26,000 -19% 01 Apr 2024 31 Mar 2025 10-K 27 Jun 2025 2025 FY
2023 $138,000 -$172,000 -55% 01 Apr 2023 31 Mar 2024 10-K 27 Jun 2025 2025 FY
2022 $310,000 +$74,000 +31% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024 2024 FY
2021 $236,000 -$1,234,000 -84% 01 Apr 2021 31 Mar 2022 10-K 07 Jul 2023 2023 FY
2020 $1,470,000 -$2,919,000 -67% 01 Apr 2020 31 Mar 2021 10-K 23 Jun 2022 2022 FY
2019 $4,389,000 +$4,374,000 +29160% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021 2021 FY
2018 $15,000 -$121,000 -89% 01 Apr 2018 31 Mar 2019 10-K 13 Jul 2020 2020 FY
2017 $136,000 -$9,677 -6.6% 01 Apr 2017 31 Mar 2018 10-K 14 Jun 2019 2019 FY
2016 $145,677 +$23,492 +19% 01 Apr 2016 31 Mar 2017 10-K 21 Jun 2018 2018 FY
2015 $122,185 +$45,658 +60% 01 Apr 2015 31 Mar 2016 10-K 14 Jul 2017 2017 FY
2014 $76,527 +$68,042 +802% 01 Apr 2014 31 Mar 2015 10-K 14 Jul 2016 2016 FY
2013 $8,485 -$317,593 -97% 01 Apr 2013 31 Mar 2014 10-K 14 Jul 2015 2015 FY
2012 $326,078 +$320,598 +5850% 01 Apr 2012 31 Mar 2013 10-K 15 Jul 2014 2014 FY
2011 $5,480 -$279,961 -98% 01 Apr 2011 31 Mar 2012 10-K 15 Jul 2014 2013 FY
2010 $285,441 01 Apr 2010 31 Mar 2011 10-K 16 Jul 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.